Repurposing Duloxetine as a Potent Butyrylcholinesterase Inhibitor: Potential Cholinergic Enhancing Benefits for Elderly Individuals with Depression and Cognitive Impairment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Repurposing Duloxetine as a Potent Butyrylcholinesterase Inhibitor: Potential Cholinergic Enhancing Benefits for Elderly Individuals with Depression and Cognitive Impairment

Published:2024-08-21 Issue:35 Volume:9 Page:37299-37309
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Darreh-Shori Taher¹^ORCID,Baidya Anurag T. K.²,Brouwer Medea¹^ORCID,Kumar Amit¹^ORCID,Kumar Rajnish²^ORCID

Affiliation:

1. Division of Clinical Geriatrics, Centre for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, NEO, Seventh Floor, 141 52 Stockholm, Sweden

2. Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (B.H.U.), Varanasi 221005, Uttar Pradesh, India

Funder

Stiftelsen Sigurd and Elsa Goljes Minne

Stiftelsen f?r Gamla Tj?narinnor

Vetenskapsr?det

?hl?n-stiftelsen

Demensfonden

Tore Nilsons Stiftelse f?r Medicinsk Forskning

Magnus Bergvalls Stiftelse

Alzheimerfonden

Olle Engkvists Stiftelse

Gun och Bertil Stohnes Stiftelse

Karolinska Institutet Geriatrics Foundation

Alzheimer Association

Karolinska Institutet Research Foundation

Gunvor and Josef An?rs Foundation

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.4c05089

Reference61 articles.

1. Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease

2. MicroRNA-132 Potentiates Cholinergic Anti-Inflammatory Signaling by Targeting Acetylcholinesterase

3. Association between butyrylcholinesterase activity and low-grade systemic inflammation

4. A Review of Butyrylcholinesterase as a Therapeutic Target in the Treatment of Alzheimer’s Disease

5. Butyrylcholinesterase: An Important New Target in Alzheimer's Disease Therapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3